Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study

被引：0
|
作者：
Luca Triggiani
Rosario Mazzola
Stefano Maria Magrini
Gianluca Ingrosso
Paolo Borghetti
Fabio Trippa
Andrea Lancia
Beatrice Detti
Giulio Francolini
Fabio Matrone
Roberto Bortolus
Giuseppe Fanetti
Ernesto Maranzano
Francesco Pasqualetti
Fabiola Paiar
Marco Lorenzo Bonù
Alessandro Magli
Alessio Bruni
Ercole Mazzeo
Ciro Franzese
Marta Scorsetti
Filippo Alongi
Barbara Alicja Jereczek-Fossa
Piet Ost
Michela Buglione
机构：
[1] University and Spedali Civili Hospital,Radiation Oncology Department
[2] IRCCS,Radiation Oncology Department
[3] Sacro Cuore Don Calabria Hospital,Department of Radiation Oncology, Policlinico Tor Vergata
[4] University of Rome,Radiation Oncology Centre
[5] “S. Maria” Hospital,Department of Radiation Oncology
[6] University of Florence,Department of Radiation Oncology
[7] Azienda Ospedaliero-Universitaria Careggi,Department of Oncology and Hemato
[8] Centro di Riferimento Oncologico di Aviano CRO-IRCCS,oncology
[9] University of Milan,Division of Radiotherapy
[10] IEO European Institute of Oncology,Department of Radiation Oncology
[11] IRCCS,Department of Radiation Oncology
[12] University Hospital S. Chiara,Radiotherapy Unit, Oncology and Hematology Department
[13] University Hospital of Udine,IRCCS, Radiotherapy and Radiosurgery Department
[14] ASUIUD,Department of Radiation Oncology
[15] University Hospital of Modena,Department of Biomedical Sciences
[16] Humanitas University Hospital,undefined
[17] Ghent University Hospital,undefined
[18] Humanitas University,undefined
来源：
World Journal of Urology | 2019年 / 37卷
关键词：
Prostate cancer; SBRT; CRPC; Metastasis-directed therapy; Radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2631 / 2637
页数：6
相关论文
共 50 条
  • [31] The Role of Local Prostate and Metastasis-Directed Radiotherapy in the Treatment of Oligometastatic Prostate Cancer
    Choi, S. H.
    Lee, J. G.
    Cho, J. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E373 - E373
  • [32] ICEPAC: A phase II multicenter study of avelumab combined with stereotactic ablative body radiotherapy (SABR) in metastatic castration-resistant prostate cancer (mCRPC)
    Azad, Arun
    Spain, Lavinia Anne
    Anton, Angelyn
    Gan, Chun Loo
    Garrett, Linda
    Chang, Deborah
    Bennett, Caitlin
    Kothari, Gargi
    Shaw, Mark
    Parente, Phillip
    Pezaro, Carmel Jo
    Tran, Ben
    Siva, Shankar
    Kwan, Edmond Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [33] Stereotactic body radiotherapy to lymph nodes in oligoprogressive castration-resistant prostate cancer patients: a post hoc analysis from two phase I clinical trials
    D. Pezzulla
    G. Macchia
    S. Cilla
    M. Buwenge
    M. Ferro
    P. Bonome
    C. Romano
    A. Zamagni
    V. Valentini
    A. G. Morganti
    F. Deodato
    Clinical & Experimental Metastasis, 2021, 38 : 519 - 526
  • [34] Stereotactic body radiotherapy to lymph nodes in oligoprogressive castration-resistant prostate cancer patients: a post hoc analysis from two phase I clinical trials
    Pezzulla, D.
    Macchia, G.
    Cilla, S.
    Buwenge, M.
    Ferro, M.
    Bonome, P.
    Romano, C.
    Zamagni, A.
    Valentini, V.
    Morganti, A. G.
    Deodato, F.
    CLINICAL & EXPERIMENTAL METASTASIS, 2021, 38 (06) : 519 - 526
  • [35] Metastasis-directed therapy in prostate cancer
    Borkowetz, Angelika
    Hoelscher, Tobias
    UROLOGIE, 2024, 63 (03): : 225 - 233
  • [36] Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer
    Kawai, Taketo
    Taguchi, Satoru
    Nozaki, Keina
    Kimura, Naoki
    Oshina, Takahiro
    Iwaki, Takuya
    Matsui, Hotaka
    Niimi, Aya
    Kamei, Jun
    Akiyama, Yoshiyuki
    Yamada, Yuta
    Sato, Yusuke
    Yamada, Daisuke
    Kaneko, Tomoyuki
    Sawayanagi, Subaru
    Nakayama, Hidetsugu
    Minamimoto, Ryogo
    Yamashita, Hideomi
    Miyazaki, Hideyo
    Fujimura, Tetsuya
    Nakagawa, Tohru
    Kume, Haruki
    PROSTATE INTERNATIONAL, 2023, 11 (04) : 239 - 246
  • [37] Prevalence of oligoprogressive, metastatic castration-resistant prostate cancer (mCRPC) amenable to stereotactic ablative radiotherapy (SABR) in men undergoing abiraterone acetate (AA) therapy.
    McDonald, Erica
    Cheng, Sierra
    Arciero, Vanessa S.
    Saluja, Ronak
    Zukotynski, Katherine A.
    Cheung, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [38] Prevalence of oligoprogressive, metastatic castration-resistant prostate cancer (mCRPC) amenable to stereotactic ablative radiotherapy (SABR) in men undergoing abiraterone acetate (AA) therapy.
    McDonald, Erica
    Cheng, Sierra
    Arciero, Vanessa Sarah
    Saluja, Ronak
    Zukotynski, Katherine A.
    Cheung, Patrick
    Emmenegger, Urban
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Somatic Alterations Contributing to Metastasis of a Castration-Resistant Prostate Cancer
    Nickerson, Michael L.
    Im, Kate M.
    Misner, Kevin J.
    Tan, Wei
    Lou, Hong
    Gold, Bert
    Wells, David W.
    Bravo, Hector C.
    Fredrikson, Karin M.
    Harkins, Timothy T.
    Milos, Patrice
    Zbar, Berton
    Linehan, W. Marston
    Yeager, Meredith
    Andresson, Thorkell
    Dean, Michael
    Bova, G. Steven
    HUMAN MUTATION, 2013, 34 (09) : 1231 - 1241
  • [40] Narrative review of local prostate and metastasis-directed radiotherapy in the treatment of metastatic prostate cancer
    Terada, Naoki
    Aizawa, Rihito
    Nihei, Keiji
    Shiota, Masaki
    Kojima, Takahiro
    Kimura, Takahiro
    Inoue, Takahiro
    Kitamura, Hiroshi
    Sugimoto, Mikio
    Nishiyama, Hiroyuki
    Mizowaki, Takashi
    Kamoto, Toshiyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (06) : 633 - 641
12345